AstraZeneca PLC Earning Date (AZN)

USA |NASDAQ |USD |ADR

AZN Earnings Date

|
Report Date Period Ending EPS Forecast Last Quarter's EPS Last Year's EPS
Jul 29, 2022 (est) Jun 30, 2022 - $0.95 $0.45
Report Date Period Ending Revenue Forecast Last Quarter’s Revenue Last Year’s Revenue
Jul 29, 2022 (est) Jun 30, 2022 - $11.39B $8.22B

Astrazeneca Plc's next estimated earnings date (based on same quarter last year's date) is Jul 29, 2022 for the fiscal quarter ending Jun 30, 2022.

AZN Earnings Date & History Chart

AZN Earnings & Revenue Forecast

AZN Earnings Forecast

|
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Jun 2022 1 $0.80 $0.80 $0.80
Sep 2022 1 $0.80 $0.80 $0.80
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2022 2 $3.32 $3.26 $3.38
Dec 2023 3 $5.12 $3.75 $7.60

AZN Earnings Revision Trend

|
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Jun 2022 0 / 0 $0.83 $0.83 $0.00
Sep 2022 0 / 1 $0.87 $0.87 $0.00
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Dec 2022 2 / 0 $4.43 $3.21 $3.90
Dec 2023 1 / 1 $5.12 $3.81 $3.90

AZN Revenue Forecast

|
Period End # of Analysts Revenue Forecast Low Revenue Forecast High Revenue Forecast
Jun 2022 3 $10.73B $10.58B $10.94B
Sep 2022 3 $10.71B $10.27B $10.97B
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2022 4 $43.79B $42.80B $44.33B
Dec 2023 4 $45.88B $44.68B $46.85B

AZN Earnings Date & Revenue History

AZN Earnings History

|
Show More
Show More

AZN Revenue History

|
Show More
Show More

Astrazeneca Plc Next Earnings Date & Report

AZN Apr 2022 (FQ) Earnings Date & Report Preview

AZN's next estimated earnings date (based on same quarter last year's report date) is Jul 29, 2022 for the fiscal quarter ending Jun 30, 2022.

Astrazeneca Plc Previous Earnings Dates & Reports

AZN Previous Earnings Date & Report Recap: Mar 2022 (FQ)

Astrazeneca Plc's previous earnings date was Apr 29, 2022 for its fiscal quarter ended Mar 31, 2022.

AZN's earnings per share (EPS) was $0.95, beating the consensus analysts forecast of $0.83 by 14.46%.

The EPS was higher than the previous fiscal quarter (Dec 2021) by 13.10%, and higher than the same period a year before (Mar 2021) by 16.56%.

Revenues were $11.39B, better than the forecast of $10.99B by 3.63%, down by -5.17% from the previous quarter , and up by 55.60% from the same period last year.

The company reported a net income of $386.00M.

Free cash flow for the quarter was $2.87B , compared to $700.00M last quarter and $1.47B a year before.

AZN ended the quarter with $31.10B in total debt, an increase of 1.03% compared to the previous quarter, and an increase of 54.48% compared to the same quarter a year before.

AZN Previous Earnings Date & Report Recap: Dec 2021 (FY)

Astrazeneca Plc's previous annual earnings date was Feb 10, 2022 for its fiscal year ended Dec 31, 2021.

AZN's earnings per share (EPS) was $2.65, missing the consensus analysts forecast of $3.21 by -17.60% , and higher than the previous year's EPS (Dec 2020) by 31.27%.

Revenues were $37.42B, better than the forecast of $36.27B by 3.17%, and up by 40.58% from previous year's revenue.

The company reported a net income of $112.00M, -96.50% lower than the previous year.

Astrazeneca Plc reported a free cash flow of $3.76B for its fiscal year, compared to $2.19B a year ago.

The company ended the fiscal year with $30.78B in total debt, an increase of 54.75% compared to the previous year.